mesalamine has been researched along with Abdominal Pain in 30 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients who received mesalamine plus the mixture of beta-glucan, inositol and digestive enzymes (group A) reported a reduction in abdominal pain together with reduction in bloating and flatulence after four weeks of treatment." | 9.24 | Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. ( Cosco, C; Cosco, V; Doldo, P; Garieri, P; Mancina, RM; Ruggiero, G; Spagnuolo, R, 2017) |
| "Twenty patients who developed diarrhea-predominant IBS after gastroenteritis were randomized to receive mesalamine (Asacol®) 1." | 9.16 | Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study. ( Al-Suqi, M; Fang, JC; Hale, DC; Stoddard, GJ; Tuteja, AK, 2012) |
| "Mesalamine suppositories have been used widely for the treatment of distal ulcerative colitis and considered to be safer than systemic administration for its limited systemic absorption." | 5.40 | Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity. ( Ding, H; Hu, J; Hu, XY; Liu, XC; Mei, Q; Xu, JM, 2014) |
| "Patients who received mesalamine plus the mixture of beta-glucan, inositol and digestive enzymes (group A) reported a reduction in abdominal pain together with reduction in bloating and flatulence after four weeks of treatment." | 5.24 | Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. ( Cosco, C; Cosco, V; Doldo, P; Garieri, P; Mancina, RM; Ruggiero, G; Spagnuolo, R, 2017) |
| "Twenty patients who developed diarrhea-predominant IBS after gastroenteritis were randomized to receive mesalamine (Asacol®) 1." | 5.16 | Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study. ( Al-Suqi, M; Fang, JC; Hale, DC; Stoddard, GJ; Tuteja, AK, 2012) |
| "Although oral mesalamine is the first-choice drug for treating mild-to-moderate ulcerative colitis (UC), some patients show symptoms of intolerance, including exacerbation of diarrhea and abdominal pain." | 4.02 | Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. ( Fujiwara, A; Higashi, R; Hiraoka, S; Inokuchi, T; Kato, J; Matsueda, K; Miyaike, J; Moritou, Y; Okada, H; Suzuki, S; Takagi, S; Takahara, M; Toyokawa, T, 2021) |
| "5-ASA is used as first-line therapy for ulcerative colitis." | 3.01 | Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis. ( Kanai, T; Kiyohara, H; Mikami, Y; Mizushima, I; Suzuki, S; Tsunoda, J, 2023) |
| "Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice." | 2.61 | The culprit of mesalamine intolerance: case series and literature review. ( Fu, Y; Hong, F; Quan, R; Xie, C; Yan, W; Zou, K, 2019) |
| "Segmental colitis associated with colonic diverticulosis is a new and emerging entity." | 2.48 | Segmental colitis associated with diverticulosis: systematic evaluation of 486 cases with meta-analysis. ( Hoda, KK; Mann, NS, 2012) |
| "Eosinophilic colitis is a rare mostly self-limiting disease affecting middle-aged adults." | 1.40 | Eosinophilic colitis is a sporadic self-limited disease of middle-aged people: a population-based study. ( Alfadda, AA; Shaffer, EA; Storr, MA; Urbanski, SJ, 2014) |
| "Mesalamine suppositories have been used widely for the treatment of distal ulcerative colitis and considered to be safer than systemic administration for its limited systemic absorption." | 1.40 | Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity. ( Ding, H; Hu, J; Hu, XY; Liu, XC; Mei, Q; Xu, JM, 2014) |
| "Diversion colitis is thought to result from nutritional deficiencies secondary to fecal diversion." | 1.30 | Diversion colitis: a cause of abdominal discomfort in spinal cord injury patients with colostomy. ( Chuang, TY; Francisco, GE; Lai, JM; Strayer, JR, 1997) |
| "Treatment with hydroxyurea was effective in lowering the thrombocyte count." | 1.30 | [Clinical decision making in family practice. A patient with abdominal pain and chills]. ( de Meijer, PH; Meinders, AE; Schippers, EF, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 17 (56.67) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikami, Y | 1 |
| Tsunoda, J | 1 |
| Suzuki, S | 2 |
| Mizushima, I | 1 |
| Kiyohara, H | 1 |
| Kanai, T | 1 |
| Hiraoka, S | 1 |
| Fujiwara, A | 1 |
| Toyokawa, T | 1 |
| Higashi, R | 1 |
| Moritou, Y | 1 |
| Takagi, S | 1 |
| Matsueda, K | 1 |
| Miyaike, J | 1 |
| Inokuchi, T | 1 |
| Takahara, M | 1 |
| Kato, J | 1 |
| Okada, H | 1 |
| Senthamizh, T | 1 |
| Senthamizhselvan, K | 1 |
| Sahoo, NK | 1 |
| Kaliaperumal, S | 1 |
| Spagnuolo, R | 1 |
| Cosco, C | 1 |
| Mancina, RM | 1 |
| Ruggiero, G | 1 |
| Garieri, P | 1 |
| Cosco, V | 1 |
| Doldo, P | 1 |
| Alamo, RZ | 1 |
| Quigley, EMM | 1 |
| Soga, K | 1 |
| Itani, K | 1 |
| Xie, C | 1 |
| Quan, R | 1 |
| Hong, F | 1 |
| Zou, K | 1 |
| Yan, W | 1 |
| Fu, Y | 1 |
| Kruis, W | 1 |
| Meier, E | 1 |
| Schumacher, M | 1 |
| Mickisch, O | 1 |
| Greinwald, R | 1 |
| Mueller, R | 1 |
| Mann, NS | 1 |
| Hoda, KK | 1 |
| Tursi, A | 3 |
| Brandimarte, G | 2 |
| Elisei, W | 2 |
| Picchio, M | 2 |
| Forti, G | 1 |
| Pianese, G | 1 |
| Rodino, S | 1 |
| D'Amico, T | 1 |
| Sacca, N | 1 |
| Portincasa, P | 1 |
| Capezzuto, E | 1 |
| Lattanzio, R | 1 |
| Spadaccini, A | 1 |
| Fiorella, S | 1 |
| Polimeni, F | 1 |
| Polimeni, N | 1 |
| Stoppino, V | 1 |
| Stoppino, G | 1 |
| Giorgetti, GM | 1 |
| Aiello, F | 1 |
| Danese, S | 1 |
| Alfadda, AA | 1 |
| Shaffer, EA | 1 |
| Urbanski, SJ | 1 |
| Storr, MA | 1 |
| Snipelisky, DF | 1 |
| Cable, CA | 1 |
| Maniaci, MJ | 1 |
| Ding, H | 1 |
| Liu, XC | 1 |
| Mei, Q | 1 |
| Xu, JM | 1 |
| Hu, XY | 1 |
| Hu, J | 1 |
| Schorr, M | 1 |
| Vaidya, A | 1 |
| Schulte, S | 1 |
| Todd, DJ | 1 |
| Conant, A | 1 |
| Di Mario, F | 1 |
| Scarpignato, C | 1 |
| Lawlor, G | 1 |
| Ahmed, A | 1 |
| Moss, AC | 1 |
| Strate, LL | 1 |
| Modi, R | 1 |
| Cohen, E | 1 |
| Spiegel, BM | 1 |
| Tuteja, AK | 1 |
| Fang, JC | 1 |
| Al-Suqi, M | 1 |
| Stoddard, GJ | 1 |
| Hale, DC | 1 |
| Leighton, MP | 1 |
| Lam, C | 1 |
| Mehta, S | 1 |
| Spiller, RC | 1 |
| Hartwich, SA | 1 |
| Ikeda, M | 1 |
| Najima, M | 1 |
| Morizane, C | 1 |
| Ueno, H | 1 |
| Okusaka, T | 1 |
| Freeman, HJ | 1 |
| Lai, JM | 1 |
| Chuang, TY | 1 |
| Francisco, GE | 1 |
| Strayer, JR | 1 |
| Oren, R | 1 |
| Moshkowitz, M | 1 |
| Odes, S | 1 |
| Becker, S | 1 |
| Keter, D | 1 |
| Pomeranz, I | 1 |
| Shirin, H | 1 |
| Shirin, C | 1 |
| Reisfeld, I | 1 |
| Broide, E | 1 |
| Lavy, A | 1 |
| Fich, A | 1 |
| Eliakim, R | 1 |
| Patz, J | 1 |
| Villa, Y | 1 |
| Arber, N | 1 |
| Gilat, T | 1 |
| Schippers, EF | 1 |
| de Meijer, PH | 1 |
| Meinders, AE | 1 |
| Abdo, AA | 1 |
| Zetler, PJ | 1 |
| Halparin, LS | 1 |
| Iofel, E | 1 |
| Chawla, A | 1 |
| Daum, F | 1 |
| Markowitz, J | 1 |
| Butt, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double-blind, Randomised, Placebo-controlled, Parallel-group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Pellets vs. Placebo in Diverticular Disease[NCT01627262] | Phase 2 | 123 participants (Actual) | Interventional | 2002-05-31 | Completed | ||
| Mesalazine and/or Lactobacillus Casei in Maintaining Remission of Symptomatic Uncomplicated Diverticular Disease of the Colon: a Double-blind, Double-dummy, Placebo-controlled Study[NCT01534754] | Phase 4 | 250 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [NCT02003807] | 102 participants (Actual) | Observational | 2013-07-31 | Completed | |||
| Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics[NCT02785549] | Phase 4 | 480 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| Prevalence of Segmental Colitis Associated With Colic Diverticulosis (SCAD): an Observational Study[NCT04279821] | 50 participants (Anticipated) | Observational | 2020-02-01 | Recruiting | |||
| Risk-stratified Randomized Controlled Trial in Paediatric Crohn Disease:Methotrexate vs Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course, respectively-a Treatment Strategy[NCT02852694] | Phase 4 | 312 participants (Anticipated) | Interventional | 2017-02-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for mesalamine and Abdominal Pain
| Article | Year |
|---|---|
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis.
Topics: Abdominal Pain; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; | 2023 |
Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diverticulosis, Co | 2019 |
The culprit of mesalamine intolerance: case series and literature review.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diarrhea; Drug Eruptio | 2019 |
Segmental colitis associated with diverticulosis: systematic evaluation of 486 cases with meta-analysis.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Colitis; Colonosco | 2012 |
37-year-old man with abdominal pain.
Topics: Abdominal Pain; Adult; Colitis, Ulcerative; Colonoscopy; Emergency Service, Hospital; Follow-Up Stud | 2014 |
Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
Topics: Abdominal Pain; Acute Disease; Age Distribution; Anti-Infective Agents; Anti-Inflammatory Agents, No | 2012 |
Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
Topics: Abdominal Pain; Acute Disease; Age Distribution; Anti-Infective Agents; Anti-Inflammatory Agents, No | 2012 |
Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
Topics: Abdominal Pain; Acute Disease; Age Distribution; Anti-Infective Agents; Anti-Inflammatory Agents, No | 2012 |
Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
Topics: Abdominal Pain; Acute Disease; Age Distribution; Anti-Infective Agents; Anti-Inflammatory Agents, No | 2012 |
[Palliative therapy in patients with biliary tract cancer].
Topics: Abdominal Pain; Analgesics; Antineoplastic Agents; Back Pain; Biliary Tract Neoplasms; Drainage; Fee | 2006 |
Outpatient management of inflammatory bowel disease. Let's keep it as simple as possible.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Ambulatory Care; Aminosalicylic Acids; Anus Diseases; Diarr | 1992 |
6 trials available for mesalamine and Abdominal Pain
| Article | Year |
|---|---|
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Biological Factors; Drug Comb | 2017 |
Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diverticulosis, Co | 2013 |
Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diverticulum, Colon; Double-Blind Met | 2013 |
Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Diarrhea; Dou | 2012 |
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Clinical Protocols; Defecation; Dia | 2013 |
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflamm | 1997 |
16 other studies available for mesalamine and Abdominal Pain
| Article | Year |
|---|---|
Multicenter survey on mesalamine intolerance in patients with ulcerative colitis.
Topics: Abdominal Pain; Administration, Oral; Adult; Colitis, Ulcerative; Diarrhea; Disease Progression; Fem | 2021 |
Panuveitis in a patient with active Crohn's disease.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budes | 2021 |
Hyposensitization trial using salazosulfapyridine in a case of mesalamine intolerance.
Topics: Abdominal Pain; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; | 2019 |
Eosinophilic colitis is a sporadic self-limited disease of middle-aged people: a population-based study.
Topics: Abdominal Pain; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis; Colon | 2014 |
Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Di | 2014 |
Interactive medical case. A man with diarrhea and back pain.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Back Pain; Colitis, Ulcerative; Colon; Colonoscopy; | 2015 |
Prognostic Role of the Endoscopic Classification "DICA".
Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Colon; Colonoscop | 2016 |
Once-daily mesalamine granules for ulcerative colitis.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colitis, Ulcerati | 2010 |
Pill impaction mimicking appendicitis in ulcerative colitis.
Topics: Abdominal Pain; Appendicitis; Colitis, Ulcerative; Diagnosis, Differential; Endoscopy, Gastrointesti | 2012 |
You're the flight surgeon. Crohn's disease.
Topics: Abdominal Pain; Adult; Aerospace Medicine; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; D | 2004 |
Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome).
Topics: Abdominal Pain; Adult; Age Distribution; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Dia | 2008 |
Diversion colitis: a cause of abdominal discomfort in spinal cord injury patients with colostomy.
Topics: Abdominal Pain; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colostomy; H | 1997 |
[Clinical decision making in family practice. A patient with abdominal pain and chills].
Topics: Abdominal Pain; Aged; Aged, 80 and over; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combi | 1998 |
Familial microscopic colitis.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis; Colonoscopy; Consti | 2001 |
Oral balsalazide (Colazal) for ulcerative colitis.
Topics: Abdominal Pain; Administration, Oral; Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; | 2001 |
Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Diarrhea; Female; Humans; Infla | 2002 |